[Hybrid Seminar held on November 11th] How to use AI to search for new targets in Stevens-Johnson syndrome | Rare Disease Analysis Series
The theme this time is "Stevens-Johnson syndrome".
Stevens-Johnson syndrome is a rare disease characterized by a rash and burn-like symptoms accompanied by high fever on the skin and mucous membranes of the entire body. The main cause is believed to be medicines, but some cases are known to be related to viral infections. In many cases, patients recover with treatment, but in severe cases, they may die from sepsis or multiple organ failure.
In this seminar, we will show you how to effectively use KIBIT Amanogawa to gain research insights by demonstrating how to use paper search AI to extract genes related to Stevens-Johnson syndrome and hypothesize therapeutic targets.
[Date and time] Thursday, November 2024, 11 14:11~40:12
* Demo experience session (real-life venue only): Thursday, July 2024, 11 14:12-30:13 (free to leave)
[Format] Online (Zoom Webinars) & real venue held simultaneously
*Bento and drinks will be provided at the real venue.Please join us as a luncheon seminar.
[Venue] FRONTEO Co., Ltd. Shinagawa Head Office 4th floor AI Tech Lounge
(address 108-0075-2 Konan, Minato-ku, Tokyo 12-23 Meishan Takahama Building）
*Capacity: 10 people (first-come, first-served basis. If the capacity is exceeded, you will be placed on a waiting list for cancellations)
[Participation conditions]
We kindly ask that you refrain from applying if you are using the free address, if you are in the same industry as us, or if you do not know your affiliation.When accessing Zoom on the day, please enter your name and email address that you entered at the time of application in the entry field for Zoom participation.
FRONTEO Inc.
Life Science AI Business Headquarters
AI drug discovery team manager
Go Nakazono
Majored in applied physics at Fukuoka University Faculty of Science.
Worked as a key account manager in BtoB business in the advertising industry.
In the pharmaceutical industry, he has experience in MR, marketing, academics, etc., mainly targeting rare diseases, blood diseases, and pediatric diseases. His previous job was as an area manager at Takeda Pharmaceutical Company.
Currently working on expanding the AI drug discovery business at the Life Science AI Business Headquarters.
FRONTEO Inc.
KIBIT Solutions Promotion Department
AI Consulting Team Manager
Shuhei Narita
Experienced in physical and chemical analysis in the CMC area, analysis using microorganisms and cells, and biopharmaceutical analysis at a pharmaceutical analysis contract company. After that, he was in charge of business development and POC program manager at CRO, and has a rich track record of formulating business plans and providing consultation from the early stages of drug development to licensing out, mainly for bio-ventures and academia.
Currently belongs to FRONTEO Co., Ltd. Customer Success Department, and based on past experience, works as an AI consultant in charge of the medical industry. He provides a wide range of support from introduction to operation of AI solutions, including the paper search AI system "KIBIT Amanogawa," and strives to make the best use of AI in companies.
Articles in the same category
[Online seminar held on July 7th] "Prevention" and "emergency response" regarding cases of job-changers bringing in trade secrets
[Online Seminar held on July 7] Fundamentals and Practice of US Litigation: Strategic Management for Japanese Companies with a Focus on Discovery Responses
[Online Seminar held on July 7th] Unraveling the mysteries of US patent damages
[July 7th - Seminar co-hosted by Re-grit Partners Inc. and FRONTEO Inc.] To respond to continuing problems and scandals - Shifting to a forward-looking approach that also considers potential risks -
[Online Seminar held on July 7] New threats in the digital transformation era and their risk management
[Online Seminar held on June 6th] Should Data Be Stored Within the Country?: Cross-border Application of Discovery and Government Access
[Online Seminar Held June 6th] How to Deal with, Utilize, and Apply the Security Clearance System in Companies
[Online Seminar held on June 6th] "Drug Discovery AI Factory" - an AI drug discovery support service that discovers the unknown from the known
[Online seminar held on June 6th] "Awareness-based legal affairs" protect companies ~ Investigation x Reporting Promotion and Control ~ Practical knowledge of "early response to potential problems" that practitioners should know now
